Medical

20 stories about Medical
מנכ"ל טבע החדש קור שולץ 2

Teva Shut Down New York, Washington Offices, Says CEO

23.02.18|Dror Reich
In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Enema Startup Motus GI Closes Nasdaq IPO at $17.5 Million

20.02.18|Lilach Baumer
On January, the colonoscopy add-on device company filed for an IPO on Nasdaq, looking to raise $28.8 Million
default image

CTech’s Daily Israeli Tech News Roundup

18.02.18|CTech
Teva turns to meritocracy as part of turnaround plan. On way to crypto offering, copyright protection startup makes misleading claims. Israel could be seeing lower corporate tax rate soon
מוסף שבועי 22.12.16 חממה לגידול קנאביס של חברת Breath of Life

Israel’s Cannabis Fever: Six Stories From Israel’s Growing Medical Marijuana Hub

18.02.18|CTech
Activity in the segment of cannabis-related technologies and medical cannabis has been on the rise in recent years in Israel
מנכ"ל טבע החדש קור שולץ

Teva Turns to Meritocracy as Part of Turnaround Plan

18.02.18|Dror Reich
A new policy the company is rolling out would see Teva employees compensated according to key performance indicators
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Cancer Screening Company Raises $8 Million

15.02.18|Lilach Baumer
Israel-based Smart Medical Systems manufactures an add-on device for colon screening, meant to increase detection of pre-cancerous tissue
וורן באפט 2017 ברקשייר האתוויי

Berkshire Hathaway Takes Position in Generic Drugmaker Teva

15.02.18|Lilach Baumer
The holding company disclosed a $358 million stake in the struggling company
קנאביס ג'מסרט GemmaCert

Automated Cannabis Analytics Startup GemmaCert Raises $2.25 Million

13.02.18|Lilach Baumer
The Tel Aviv-based startup developed a kettle-sized device that determines the potency of cannabis within 30 seconds, without destroying the sample
מוסף ניתוח מנתח מנתחים רופא רופאים

Israel Moves to Regulate Big Data Health Applications

12.02.18|Yoav Stoler
Several hospitals in Israel have been testing an AI software that helps doctors decide whether patients should undergo surgery, without notifying the patients
מימין ערן אדן כפיר עובד MeMed

Bacteria or Virus? Automated Blood Tests Startup MeMed Wins Department of Defense Grant

07.02.18|Omer Kabir
MeMed develops a printer-sized automated blood test device that can diagnose the source of infections in under 15 minutes, compared to days-long lab tests
חממה של BOL קנאביס

Fearing Leakage of Medical Cannabis to Recreational Users, Israel’s Ministry of Public Security is Delaying Export Licensing

05.02.18|Sefi Krupsky
Export regulations are part of a wider planned cannabis reform announced in 2016, aiming to legalize and monitor medical cannabis products in the country
חיים לייבוביץ' מנכ"ל בריינסטורם

Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member

05.02.18|Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases
מטה טבע פתח תקווה

Teva Gets Fresh Cash, Fresh Woes

04.02.18|Dror Reich
After the troubled drugmaker finalized two deals that will enable it to repay some of its debt, S&P placed it on CreditWatch negative on Friday
תל אביב מבט על מ למעלה

Danish Leo Pharma is Launching an Innovation Lab in Israel

04.02.18|Lilach Baumer
Established in 2015, Leo Pharma’s innovation lab currently operates in Copenhagen, London, Paris, and Toronto, developing digital health solutions
צ'ארלס קוך charles koch תעשיין אמריקאי

Koch Industries Completes Second Stage of Investment in Medical Device Company InSightec

01.02.18|Dror Reich
Overall, Koch has invested $100 million in the Israel-based company out of a total equity funding round of $150 million
קולפלנט דיו ביולוגי

Tissue Regeneration Company CollPlant is Coming to Nasdaq

30.01.18|Lilach Baumer
Already listed on the Tel Aviv Stock Exchange, the Israel-based company is listing on Nasdaq as part of its September investment agreement with Lichtenstein-based Alpha Capital Anstalt
default image

Pharma Company BioCanCell Raises $25 million, Plans to Go Public in the U.S.

23.01.18|Asaf Shalev
The company said it will use the funding for clinical trials of BC-819, a drug being designed to treat early stage bladder cancer
עובדי מפעל טבע נתניה

Moody’s Downgrades Teva Bond Rating to “Junk”

14.01.18|Lilach Baumer
The credit rating agency is following is the steps of Fitch, which did the same in November. Of the “big three,” only S&P Global still rates Teva as investment grade
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Enema Startup Motus GI Files for $28.8 Million Nasdaq IPO

07.01.18|Lilach Baumer
The Israel-based company develops a device that helps prepare patients better for colonoscopy
default image

Pontifax Raises a $240 Million Fifth Fund

01.01.18|Meir Orbach
Life sciences-focused venture capital firm Pontifax is expected to invest most of the new fund in the pharmaceutical industry